[Nang Kuang] Announcement regarding the approval of lifting non-compete restrictions for directors at the 2026 Annual General Meeting
Key facts
- [Nang Kuang] Announcement regarding the approval of lifting non-compete restrictions for directors at the 2026 Annual General Meeting
- Nang Kuang Pharmaceutical announced that the 2026 AGM approved the lifting of non-compete restrictions for six directors with 99.63% approval, allowing them to engage in related business activities.
- Source: PR Times
- Date: May 28, 2026
Direct answer
Nang Kuang Pharmaceutical announced that the 2026 AGM approved the lifting of non-compete restrictions for six directors with 99.63% approval, allowing them to engage in related business activities.
- Citation
- [Nang Kuang] Announcement regarding the approval of lifting non-compete restrictions for directors at the 2026 Annual General Meeting (May 28, 2026), PR Times
- Source
- PR Times
- Date
- May 28, 2026
Nang Kuang Pharmaceutical announced that the 2026 AGM approved the lifting of non-compete restrictions for six directors with 99.63% approval, allowing them to engage in related business activities.
📋 Article Processing Timeline
- 📰 Published: May 28, 2026 at 09:00
- 🔍 Collected: May 29, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 18:34 (58h 34m after Collected)
1. Date of resolution: 2026/05/28. 2. Names and titles of directors permitted to engage in competitive activities: (1) Chang Po-jen, (2) Hsu Li-chun, (3) Hsu Ya-fen, (4) Wu Ya-chuan, (5) Lin Chih-lung, (6) Wang Yu-pei. 3. Items permitted: Directors may engage in business within the company's scope for themselves or others, provided it does not harm the company's interests. 4. Duration: During their tenure. 5. Voting results: 61,844,740 votes in favor, 105,508 against. Passed with 99.63% approval. 6. Mainland China business: Not applicable.
FAQ
What is a non-compete waiver?
It allows directors to engage in business activities that might otherwise conflict with the company.
What are the key facts in this article?
Nang Kuang Pharmaceutical announced that the 2026 AGM approved the lifting of non-compete restrictions for six directors with 99.63% approval, allowing them to engage in related business activities.
What is the direct answer?
Nang Kuang Pharmaceutical announced that the 2026 AGM approved the lifting of non-compete restrictions for six directors with 99.63% approval, allowing them to engage in related business activities.